| Trial Identifier: | D4190C00023 |
| Sponsor: | MedImmune, LLC |
| NCTID:: | NCT02549651 |
| Start Date: | July 2016 |
| Primary Completion Date: | February 2019 |
| Study Completion Date: | February 2019 |
| Condition: | Lymphoma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| Spanish Translation | |
| French Translation | |
| English Translation |
| Country | Location |
|---|---|
| France | Marseille, France, 13273 |
| France | Villejuif, France, 94805 |
| Ireland | Dublin 8, Ireland |
| Ireland | Galway, Ireland |
| United Kingdom | Leicester, United Kingdom, LE1 5WW |
| United States of America, CA | La Jolla, CA, United States of America, 92093 |
| United States of America, MD | Baltimore, MD, United States of America, 21201 |
| United States of America, NC | Durham, NC, United States of America, 27710 |
| United States of America, NM | Albuquerque, NM, United States of America, 87131 |
| United States of America, SC | Charleston, SC, United States of America, 29425 |
| United States of America, TX | Dallas, TX, United States of America, 75390 |
| United States of America, TX | Houston, TX, United States of America, 77030 |
| United States of America, WI | Milwaukee, WI, United States of America, 53226 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company